ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CHRISTINA NASRAWI PH.D., F.N.P.

150 CLOVIS AVE SUITE NUMBER 105

Clovis | California | 93612

(559) 299-9088

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,546Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 619

$500K Total Retail Price of All Prescriptions

Rank: 25 out of 619

135 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 135 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 5,565 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $76 among peers.

Prescriptions per Patient

63 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LOVAZA 453 326 1 75
GABAPENTIN 385 228 2 11
CARVEDILOL 345 257 3 16
OMEPRAZOLE 333 200 4 5
NABUMETONE 297 206 5 127
VALACYCLOVIR 236 145 10 6 138
TRAMADOL HCL 235 139 7 23
ALENDRONATE SODIUM 225 167 8 14
PROAIR HFA 203 116 9 29
LOVASTATIN 202 177 10 20
ATORVASTATIN CALCIUM 193 112 11 12
FLUTICASONE PROPIONATE 192 123 12 43
GLIMEPIRIDE 192 119 12 21
AMLODIPINE BESYLATE 189 151 14 7
ADVAIR HFA 171 119 15 194
TAMSULOSIN HCL 150 114 16 47
FUROSEMIDE 136 104 17 10
SPIRIVA 131 101 18 61
AZITHROMYCIN 129 92 19 35
OXYBUTYNIN CHLORIDE ER 115 80 20 196
JANUVIA 109 63 21 39
LEVOTHYROXINE SODIUM 105 94 22 6
ZOLPIDEM TARTRATE 99 49 23 15
LEVOFLOXACIN 98 72 24 160
AGGRENOX 96 65 25 174
SINGULAIR 91 43 26 112
LOSARTAN-HYDROCHLOROTHIAZIDE 89 60 27 140
NIASPAN 87 52 28 116
LISINOPRIL 84 80 29 2
PATANOL 84 43 29 187
LOSARTAN POTASSIUM 84 52 29 17
DIOVAN HCT 82 53 32 134
MONTELUKAST SODIUM 81 30 33 244
CELEBREX 80 35 34 73
DONEPEZIL HCL 80 80 34 45
VENTOLIN HFA 79 57 36 152
CLINDAMYCIN HCL 77 49 37 248
MELOXICAM 76 49 38 87
ISOSORBIDE MONONITRATE ER 76 65 38 51
QVAR 73 49 40 167
HYDROCHLOROTHIAZIDE 72 52 41 8
BACLOFEN 69 36 42 60
METOPROLOL TARTRATE 66 52 43 19
SIMVASTATIN 66 47 43 3
ACTOS 66 34 43 85
CEPHALEXIN 63 41 46 124
DIOVAN 62 50 47 40
NEXIUM 62 28 47 96
NATEGLINIDE 60 30 49 280
ONGLYZA 60 38 49 111
PROPRANOLOL HCL 57 31 51 136
PRAMIPEXOLE DIHYDROCHLORIDE 55 40 52 302
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.